[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.92.239. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Commentary
Health Care Reform
April 12, 2010

Comparative Effectiveness ResearchCritically Intertwined With Health Care Reform and the Future of Biomedical Innovation

Author Affiliations

Author Affiliations: External Medical and Scientific Affairs (Dr Murray) and US Outcomes Research (Dr McElwee), Global Human Health, Merck & Co Inc, North Wales, Pennsylvania.

Arch Intern Med. 2010;170(7):596-599. doi:10.1001/archinternmed.2010.50

The current health care reform efforts have been summarized by some as being focused on 2 goals: social justice and value.1 These goals are highly interdependent, particularly in our current economic state. The ability to distinguish among a broad array of potential approaches and interventions based on their varying value becomes a required enabler of increasing access (social justice), while balancing cost and quality (value). Comparative effectiveness research (CER) is an essential element for success in these pursuits and is also vital to the future of biopharmaceutical development.

First Page Preview View Large
First page PDF preview
First page PDF preview
×